Tango pancreatic cancer combo shows promise at ESMO; Moderna-Merck vaccine data released

At the ESMO conference, Tango Therapeutics presented striking efficacy data for its pancreatic cancer combination therapy, building on prior success from Revolution Medicines. Separately, detailed data on Moderna and Merck's cancer vaccine was released early. The clinical outcomes are promising but remain early-stage, with regulatory and commercial implications uncertain.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works